CTMX logo

CytomX Therapeutics, Inc.

CTMX
Healthcare|Biotechnology|US
$2.19
+0.05 (+2.34%)
Tangible Book / Share
$1.29
Cash / Share
$1.59
Next Earnings Report
Feb 24, 2027
EPS est. -$0.10 · Revenue est. $5.3M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Mar 18, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Nov 2027
Est. completion
P1Solid Tumor, Adult
First In Human Study of CX-2051 in Advanced Solid Tumors
NCT06265688n=160
Feb 2028
Est. completion
P1Solid Tumor, Adult
First In Human Study of CX-801 in Advanced Solid Tumors
NCT06462794n=121

Recent Press Releases

CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
Nov 5, 2026 · GlobeNewsWire
CytomX Therapeutics to Present at Upcoming November Investor Conferences
Nov 2, 2026 · GlobeNewsWire
CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 29, 2026 · GlobeNewsWire
CytomX Therapeutics to Present at Upcoming September Investor Conferences
Sep 1, 2026 · GlobeNewsWire
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Aug 27, 2026 · GlobeNewsWire

SEC Filings (80)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Oct 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 2026S-8Employee stock planDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 27, 20268-KMaterial eventDocumentIndex
Jun 22, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 20, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 18, 2026424B5Offering prospectusDocumentIndex
Mar 16, 2026424B5Offering prospectusDocumentIndex
Mar 16, 2026S-3ASRShelf registrationDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Mar 16, 202610-KAnnual reportDocumentIndex
Mar 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 7, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex